Prospective Measurement of Post-Treatment Lymphedema

Completed

Conditions studied: Melanoma

In brief

The goal of this study is to measure the amount of limb swelling (lymphedema) that sometimes occurs after melanoma treatment, and to find out how people feel and react to the diagnosis and treatment of melanoma.

Key facts

Study ID

NCT00495950

Run by

M.D. Anderson Cancer Center

People needed

350

Starts

2006-05-01

Expected to finish

2016-11-01

Last updated by the study team

2016-11-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a confirmed diagnosis (M.D. Anderson pathology) of invasive cutaneous melanoma (stages I-III) will be recruited for participation as they present for their initial clinical evaluation to the University of Texas M.D. Anderson Melanoma and Skin Center.
• Prior to surgical treatment
• Patients who can knowledgeably and voluntarily provide an informed consent to participate. The informed consent will be signed and dated.
• Fluent in English.
• At least 18 years of age.

You may not qualify if…

• Patients with a prior history of lymphedema or melanoma prior to treatment.
• Patients who are unable to consent due to other medical illnesses or disorientation to person, place or time.
• Patients with known distant metastatic disease (Stage IV).
• Patients with implanted device (pace maker), orthopedic implants, and metal frames.
• Presence of concurrent malignancy that requires active treatment, such as chemotherapy or biotherapy, prior to enrollment.

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.